Maki Nazli, Moitra Karobi, Silver Cara, Ghosh Pratiti, Chattopadhyay Apurba, Dey Saibal
Department of Biochemistry and Molecular Biology, Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, 4301 Jones Bridge Road, Bethesda, Maryland 20814-4799, USA.
Biochemistry. 2006 Feb 28;45(8):2739-51. doi: 10.1021/bi0521745.
The human P-glycoprotein (Pgp, ABCB1) is an ATP-dependent efflux pump for structurally unrelated hydrophobic compounds, conferring simultaneous resistance to and restricting bioavailability of several anticancer and antimicrobial agents. Drug transport by Pgp requires a coordinated communication between its substrate binding/translocating pathway (substrate site) and the nucleotide binding domains (NBDs or ATP sites). In this study, we demonstrate that certain thioxanthene-based Pgp modulators, such as cis-(Z)-flupentixol and its closely related analogues, effectively disrupt molecular cross talk between the substrate, and the ATP, sites without affecting the basic functional aspects of the two domains, such as substrate recognition, binding, and hydrolysis of ATP and dissociation of ADP following ATP hydrolysis. The allosteric modulator cis-(Z)-flupentixol has no effect on [alpha-(32)P]-8-azido-ATP binding to Pgp under nonhydrolytic conditions or on the K(m) for ATP during ATP hydrolysis. Both hydrolysis of ATP and vanadate-induced [alpha-(32)P]-8-azido-ADP trapping (following [alpha-(32)P]-8-azido-ATP breakdown) by Pgp are stimulated by the modulator. However, the ability of Pgp substrates (such as prazosin) to stimulate ATP hydrolysis and facilitate vanadate-induced trapping of [alpha-(32)P]-8-azido-ADP is substantially affected in the presence of cis-(Z)-flupentixol. Substrate recognition by Pgp as determined by [(125)I]iodoarylazidoprazosin ([(125)I]IAAP) binding both in the presence and in the absence of ATP is facilitated by the modulator, whereas substrate dissociation in response to vanadate trapping is considerably affected in its presence. In the Pgp F983A mutant, which is impaired in modulation by cis-(Z)-flupentixol, the modulator has a minimal effect on substrate-stimulated ATP hydrolysis as well as on substrate dissociation coupled to vanadate trapping. Finally, cis-(Z)-flupentixol has no effect on dissociation of [alpha-(32)P]-8-azido-ADP (or ADP) from vanadate-trapped Pgp, which is essential for subsequent rounds of ATP hydrolysis. Taken together, our results demonstrate a distinct mechanism of Pgp modulation that involves allosteric disruption of molecular cross talk between the substrate, and the ATP, sites without any direct interference with their individual functions.
人P-糖蛋白(Pgp,ABCB1)是一种依赖ATP的外排泵,可转运结构不相关的疏水性化合物,对多种抗癌和抗菌药物同时具有耐药性并限制其生物利用度。Pgp介导的药物转运需要其底物结合/转运途径(底物位点)与核苷酸结合结构域(NBDs或ATP位点)之间进行协调通信。在本研究中,我们证明某些噻吨类Pgp调节剂,如顺式-(Z)-氟哌噻吨及其密切相关的类似物,可有效破坏底物位点与ATP位点之间的分子串扰,而不影响这两个结构域的基本功能,如底物识别、结合、ATP水解以及ATP水解后ADP的解离。变构调节剂顺式-(Z)-氟哌噻吨在非水解条件下对[α-(32)P]-8-叠氮基-ATP与Pgp的结合或ATP水解过程中对ATP的米氏常数(Km)均无影响。该调节剂可刺激Pgp介导的ATP水解以及钒酸盐诱导的[α-(32)P]-8-叠氮基-ADP捕获(在[α-(32)P]-8-叠氮基-ATP分解之后)。然而,在顺式-(Z)-氟哌噻吨存在的情况下,Pgp底物(如哌唑嗪)刺激ATP水解并促进钒酸盐诱导的[α-(32)P]-8-叠氮基-ADP捕获的能力受到显著影响。顺式-(Z)-氟哌噻吨可促进Pgp通过[(125)I]碘芳基叠氮哌唑嗪([(125)I]IAAP)结合来识别底物,无论有无ATP存在均如此,而在其存在的情况下,响应钒酸盐捕获的底物解离受到显著影响。在顺式-(Z)-氟哌噻吨调节功能受损的Pgp F983A突变体中,该调节剂对底物刺激的ATP水解以及与钒酸盐捕获偶联的底物解离影响极小。最后,顺式-(Z)-氟哌噻吨对钒酸盐捕获的Pgp中[α-(32)P]-8-叠氮基-ADP(或ADP)的解离没有影响,而这种解离对于后续的ATP水解至关重要。综上所述,我们的结果证明了一种独特的Pgp调节机制,该机制涉及变构破坏底物位点与ATP位点之间的分子串扰,而不会直接干扰它们各自的功能。